Introduction to a review series on emerging immunotherapies for hematologic diseases

dc.contributor.authorPaczesny, Sophie
dc.contributor.authorPavletic, Steven Z.
dc.contributor.authorBollard, Catherine M.
dc.contributor.departmentPediatrics, School of Medicineen_US
dc.date.accessioned2019-05-09T17:52:55Z
dc.date.available2019-05-09T17:52:55Z
dc.date.issued2018-06-14
dc.description.abstractImmune therapies are fast becoming paradigm-changing treatment options for patients with hematologic cancers. The field has grown exponentially as it expands to nonmalignant blood diseases. This Perspective article introduces the review series describing some of the latest advances in this field and highlighting some of the current obstacles and new opportunities for the future. Specifically, the series provides in-depth discussion on a selection of emerging immunotherapies now available to patients for hematologic diseases, including cancer vaccines, chimeric antigen receptor T cells, and immunotherapies to regulate inflammation in nonmalignant blood disorders.en_US
dc.identifier.citationPaczesny, S., Pavletic, S. Z., & Bollard, C. M. (2018). Introduction to a review series on emerging immunotherapies for hematologic diseases. Blood, 131(24), 2617–2620. doi:10.1182/blood-2018-04-840793en_US
dc.identifier.urihttps://hdl.handle.net/1805/19199
dc.language.isoen_USen_US
dc.publisherAmerican Society of Hematologyen_US
dc.relation.isversionof10.1182/blood-2018-04-840793en_US
dc.relation.journalBlooden_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectImmune therapyen_US
dc.subjectHematologic canceren_US
dc.subjectNonmalignant blood diseasesen_US
dc.subjectCancer vaccinesen_US
dc.subjectChimeric antigen receptor T cellsen_US
dc.titleIntroduction to a review series on emerging immunotherapies for hematologic diseasesen_US
dc.typeArticleen_US
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032896/en_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Introduction to a review series on emerging immunotherapies for hematologic dis.pdf
Size:
252.06 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: